These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18594480)

  • 1. Therapeutic considerations in applying rate control therapy for atrial fibrillation.
    Wyse DG
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):11-7. PubMed ID: 18594480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate control vs rhythm control strategies in atrial fibrillation.
    Wyse DG
    Prog Cardiovasc Dis; 2005; 48(2):125-38. PubMed ID: 16253652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all.
    Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX
    Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate versus rhythm control in the management of patients with atrial fibrillation.
    Pelargonio G; Prystowsky EN
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):514-21. PubMed ID: 16186849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate control in atrial fibrillation: looking beyond the average heart rate.
    Ahmad K; Dorian P
    Curr Opin Cardiol; 2006 Mar; 21(2):88-93. PubMed ID: 16470141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate versus rhythm control in atrial fibrillation.
    Anthony KK; Mauro VF
    Ann Pharmacother; 2004 May; 38(5):839-44. PubMed ID: 15039475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of drugs in pursuit of rate control strategy.
    Samii SM; Hynes BJ; Khan M; Wolbrette DL; Luck JC; Naccarelli GV
    Prog Cardiovasc Dis; 2005; 48(2):146-52. PubMed ID: 16253654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need.
    Waldo AL
    Am Heart J; 2006 Apr; 151(4):771-8. PubMed ID: 16569531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate versus rhythm control in atrial fibrillation: no one-size-fits-all.
    McClanahan AL; Curtis AB
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):891-3. PubMed ID: 20602548
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy for atrial fibrillation.
    Musco S; Conway EL; Kowey PR
    Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation.
    Wongcharoen W; Chen SA
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):311-22. PubMed ID: 19296769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies?
    Reiffel JA
    Am J Cardiol; 2008 Sep; 102(6A):3H-11H. PubMed ID: 18790109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate control in atrial fibrillation: targets, methods, resynchronization considerations.
    Heist EK; Mansour M; Ruskin JN
    Circulation; 2011 Dec; 124(24):2746-55. PubMed ID: 22155996
    [No Abstract]   [Full Text] [Related]  

  • 17. Rhythm control and increased risk of noncardiovascular death in the Atrial Fibrillation Follow-up Investigation of Rhythm Management trial.
    Boriani G; Biffi M; Mattioli S
    Circulation; 2004 Sep; 110(11):e307-8; author reply e307-8. PubMed ID: 15364827
    [No Abstract]   [Full Text] [Related]  

  • 18. Atrial fibrillation: rate versus rhythm control.
    Amani F; Smith ES
    J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
    [No Abstract]   [Full Text] [Related]  

  • 19. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
    Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm.
    Van Gelder IC; Hemels ME
    Europace; 2006 Nov; 8(11):943-9. PubMed ID: 16973685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.